Effector functions of matched sets of recombinant human IgG subclass antibodies

Judith Greenwood & Mike Clark

Running title: Effector functions of human IgG

Contents


Extra Information

Since this article was originally written the development of the CAMPATH-1 antibodies has continued but no longer as a product from Glaxo-Wellcome. For more information see the web pages for the Therapeutic Antibody Centre in Oxford.

I have also completed a more recent review of IgG structure which extends the work described here. See Clark, M (1997), Chemical Immunology 65, 88-110 Antibody Engineering IgG Effector Mechanisms. In addition there is some more online information on this topic including a useful figure marking up the residues referred to in the text of this article.


© 1998, M. Clark, adapted with permission .
Go to Mike Clark's Home-page
There have been requests for this page.